Literature DB >> 16895780

Endolymphatic sac revision for recurrent intractable Meniere's disease.

Michael M Paparella1.   

Abstract

Meniere's disease can be observed uniquely in revisions of the conservative surgical procedure for endolymphatic sac enhancement, which preserves the labyrinth, unlike destructive procedures. Genetic anatomic abnormalities in patients lead to malabsorption of endolymph and symptoms of Meniere's that are reversed by endolymphatic sac enhancement, but disabling symptoms eventually may recur in a few cases and require revisional surgery. We observe developing pathophysiologic conditions intraoperatively and have modified our techniques to accommodate the redeveloped pathogenesis we observe and avoid complications found with earlier techniques. This conservative treatment allows patients (many of whom may develop bilateral Meniere's) to retain capacity to accept cochlear implants should they become advisable later.

Entities:  

Mesh:

Year:  2006        PMID: 16895780     DOI: 10.1016/j.otc.2006.03.001

Source DB:  PubMed          Journal:  Otolaryngol Clin North Am        ISSN: 0030-6665            Impact factor:   3.346


  3 in total

1.  In vivo imaging of saccular hydrops in humans reflects sensorineural hearing loss rather than Meniere's disease symptoms.

Authors:  Arnaud Attyé; Michael Eliezer; Maud Medici; Irène Tropres; Georges Dumas; Alexandre Krainik; Sébastien Schmerber
Journal:  Eur Radiol       Date:  2018-03-21       Impact factor: 5.315

2.  Membranous labyrinth volumes in normal ears and Ménière disease: a three-dimensional reconstruction study.

Authors:  Norimasa Morita; Shin Kariya; Armin Farajzadeh Deroee; Sebahattin Cureoglu; Shigenobu Nomiya; Rie Nomiya; Tamotsu Harada; Michael M Paparella
Journal:  Laryngoscope       Date:  2009-11       Impact factor: 3.325

3.  A Comparison of Local Endolymphatic Sac Decompression, Endolymphatic Mastoid Shunt, and Wide Endolymphatic Sac Decompression in the Treatment of Intractable Meniere's Disease: A Short-Term Follow-Up Investigation.

Authors:  Guiliang Zheng; Yupeng Liu; Jingchun He; Shuna Li; Qing Zhang; Maoli Duan; Jun Yang; Yulian Jin
Journal:  Front Neurol       Date:  2022-02-10       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.